Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Laughon

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Pediatrics|July 16, 2014
Mechanisms to provide safe and effective drugs for childrenMatthew M Laughon, Daniel K Benjamin
Seminars in Fetal & Neonatal Medicine|September 9, 2009
Prevention of bronchopulmonary dysplasiaMatthew M Laughon, P Brian Smith, Carl Bose
Expert Opinion on Pharmacotherapy|September 14, 2023
Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infantsMatthew F Pizzuto, Matthew M Laughon, Wesley M Jackson
Current Opinion in Pediatrics|March 17, 2004
Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?Matthew M Laughon, Michael A Simmons, Carl L Bose
American Journal of Perinatology|February 17, 2018
Effect of Routine, Screening Head Ultrasounds on Clinical Interventions for Premature InfantsAndrew Z Heling, Matthew M Laughon, Wayne A Price
Journal of Pediatric Surgery|April 12, 2020
Gastroschisis prevalence substantially decreased from 2009 through 2018 after a 3-fold increase from 1997 to 2008Reese H Clark, John Sousa, Matthew M Laughon, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association|April 24, 2003
Integrating improvement competencies into residency education: a pilot project from a pediatric continuity clinicJulie J Mohr, Greg D Randolph, Matthew M Laughon, et al.
Journal of Pediatric Surgery|January 9, 2007
Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?Mehul V Raval, Matthew M Laughon, Carl L Bose, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 16, 2023
A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathyWesley Jackson, Daniel Gonzalez, Rachel G Greenberg, et al.
Pediatric Pulmonology|May 10, 2005
Sweat-testing in preterm and full-term infants less than 6 weeks of ageWarren Eng, Vicky A LeGrys, Michael S Schechter, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Pediatrics|July 16, 2014
Mechanisms to provide safe and effective drugs for childrenMatthew M Laughon, Daniel K Benjamin
Seminars in Fetal & Neonatal Medicine|September 9, 2009
Prevention of bronchopulmonary dysplasiaMatthew M Laughon, P Brian Smith, Carl Bose
Expert Opinion on Pharmacotherapy|September 14, 2023
Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infantsMatthew F Pizzuto, Matthew M Laughon, Wesley M Jackson
Current Opinion in Pediatrics|March 17, 2004
Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?Matthew M Laughon, Michael A Simmons, Carl L Bose
American Journal of Perinatology|February 17, 2018
Effect of Routine, Screening Head Ultrasounds on Clinical Interventions for Premature InfantsAndrew Z Heling, Matthew M Laughon, Wayne A Price
Journal of Pediatric Surgery|April 12, 2020
Gastroschisis prevalence substantially decreased from 2009 through 2018 after a 3-fold increase from 1997 to 2008Reese H Clark, John Sousa, Matthew M Laughon, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association|April 24, 2003
Integrating improvement competencies into residency education: a pilot project from a pediatric continuity clinicJulie J Mohr, Greg D Randolph, Matthew M Laughon, et al.
Journal of Pediatric Surgery|January 9, 2007
Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?Mehul V Raval, Matthew M Laughon, Carl L Bose, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 16, 2023
A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathyWesley Jackson, Daniel Gonzalez, Rachel G Greenberg, et al.
Pediatric Pulmonology|May 10, 2005
Sweat-testing in preterm and full-term infants less than 6 weeks of ageWarren Eng, Vicky A LeGrys, Michael S Schechter, et al.
Pageof 12